RxDoctor Payments DataLook up a doctor →

Christel Wheeler

Family · Decatur, ILNPI 1588133003

Payments from drug & device makers

$21,655in general payments, 2019–2025

Across 775 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Johnson & Johnson$2K
  • Lilly USA, LLC$2K
  • Janssen Scientific Affairs, LLC$1K
  • AbbVie$1K
  • Novartis$998
  • plus $12K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)73$2,610
Johnson & Johnson(2 entities)97$2,140
Lilly USA, LLC59$1,590
Janssen Scientific Affairs, LLC2$1,143
AbbVie38$1,086
Novartis60$998
Exelixis Inc.5$986
Merck53$941
Incyte Corporation27$941
Daiichi Sankyo Inc.30$718
Seagen Inc.24$713
Pfizer27$559
Pharmacyclics LLC, An Abbvie Company18$463
E.r. Squibb & Sons, L.L.C.16$447
Astellas Pharma US Inc14$422
Novocure Inc.7$392
Gilead(2 entities)17$368
Myriad Genetic Laboratories, Inc.2$314
Sanofi13$308
Eisai Inc.15$300
Genentech USA, Inc.14$273
Teva Pharmaceuticals USA, Inc.1$230
Bristol Myers Squibb13$230
Genmab U.S., Inc.9$228
Beigene USA, Inc.8$167
Ipsen Biopharmaceuticals, Inc4$153
Coherus Oncology, Inc.4$145
Rigel Pharmaceuticals, Inc.6$142
Takeda Pharmaceuticals U.S.A., Inc.7$141
Jazz Pharmaceuticals Inc.6$138
ADC Therapeutics America, Inc.6$137
G1 Therapeutics, Inc.5$137
Mirati Therapeutics, Inc.6$135
GSK8$135
Sobi, Inc7$130
Amneal Pharmaceuticals LLC5$121
Amgen7$115
Tempus AI, Inc2$103
Blueprint Medicines Corporation5$93
Geron Corporation1$90
Bayer2$87
CTI Biopharma Corp.3$86
Regeneron Healthcare Solutions, Inc.4$83
EMD Serono, Inc.4$82
Sanofi-aventis U.S. LLC1$79
AVEO Pharmaceuticals, Inc.3$63
Fennec Pharmaceuticals, Inc.1$55
Stemline Therapeutics Inc.3$51
Morphosys, US Inc.3$50
Kyowa Kirin, Inc.3$49
Adaptive Biotechnologies Corporation2$47
Beone Medicines USA, Inc.2$42
Sun Pharmaceutical Industries Inc.2$40
Boehringer Ingelheim2$34
Pharmaessentia USA Corporation2$32
Servier Pharmaceuticals LLC2$30
Madrigal Pharmaceuticals1$28
Tolmar Pharmaceuticals, Inc.2$27
Syndax Pharmaceuticals, Inc.1$27
Corcept Therapeutics1$23

How this compares

$21,655 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois →

Medicare billing

Part B allowed, 2024
$49,676
Medicare patients
292
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Decatur

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →